TERT and cancer: The stratified analysis based on Method of genotype indicated that the TERT rs10069690 polymorphism was associated with an increased risk of cancer in the Illumina (OR = 1.07, 95% CI: 1.04–1.11, p‐heterogeneity < .001, I2 = 90.9%) and MassArray groups (OR = 1.24, 95% CI: 1.10–1.40, p‐heterogeneity < .001, I2 = 75.2%) (Table 2).